anmelden
SLI
2.315,50
PKT
+6,64
PKT
+0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 25.07.14 | Roche overweight | Barclays Capital | |
| 25.07.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 24.07.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 24.07.14 | Swiss Re Verkaufen | DZ-Bank AG | |
| 24.07.14 | ABB (Asea Brown Boveri) Hold | Kelper Cheuvreux | |
| 24.07.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 24.07.14 | ABB (Asea Brown Boveri) Underweight | HSBC | |
| 24.07.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.07.14 | ABB (Asea Brown Boveri) buy | S&P Capital IQ | |
| 23.07.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 23.07.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 23.07.14 | UBS buy | UBS AG | |
| 23.07.14 | UBS Hold | Kelper Cheuvreux | |
| 23.07.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 22.07.14 | UBS buy | S&P Capital IQ | |
| 22.07.14 | UBS Hold | Société Générale Group S.A. (SG) | |
| 22.07.14 | UBS neutral | Independent Research GmbH | |
| 22.07.14 | UBS buy | Jefferies & Company Inc. | |
| 22.07.14 | UBS buy | UBS AG | |
| 21.07.14 | Novartis Underweight | Morgan Stanley | |
| 21.07.14 | Novartis Equal weight | Barclays Capital | |
| 21.07.14 | UBS buy | Citigroup Corp. | |
| 21.07.14 | UBS buy | Citigroup Corp. | |
| 21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.07.14 | Givaudan Outperform | Credit Suisse Group | |
| 18.07.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 18.07.14 | UBS overweight | JP Morgan Chase & Co. | |
| 18.07.14 | UBS buy | Goldman Sachs Group Inc. | |
| 18.07.14 | UBS Conviction Buy | Goldman Sachs Group Inc. | |
| 18.07.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 17.07.14 | Roche buy | UBS AG | |
| 17.07.14 | UBS buy | UBS AG | |
| 17.07.14 | Roche overweight | Morgan Stanley | |
| 17.07.14 | Novartis buy | S&P Capital IQ | |
| 17.07.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 17.07.14 | Holcim buy | UBS AG | |
| 17.07.14 | Holcim buy | UBS AG | |
| 16.07.14 | Givaudan buy | Nomura | |
| 15.07.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. |
